PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100. A total of 87 filers reported holding PAIN THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $89,000 | +56.1% | 100,000 | 0.0% | 0.00% | – |
| Q4 2016 | $57,000 | -43.0% | 100,000 | 0.0% | 0.00% | – |
| Q3 2016 | $100,000 | -54.3% | 100,000 | 0.0% | 0.00% | – |
| Q2 2016 | $219,000 | -1.8% | 100,000 | 0.0% | 0.00% | – |
| Q1 2016 | $223,000 | +27.4% | 100,000 | 0.0% | 0.00% | – |
| Q4 2015 | $175,000 | -4.4% | 100,000 | 0.0% | 0.00% | – |
| Q3 2015 | $183,000 | +5.8% | 100,000 | 0.0% | 0.00% | – |
| Q2 2015 | $173,000 | -13.9% | 100,000 | 0.0% | 0.00% | – |
| Q1 2015 | $201,000 | 0.0% | 100,000 | 0.0% | 0.00% | – |
| Q4 2014 | $201,000 | -48.6% | 100,000 | 0.0% | 0.00% | -100.0% |
| Q3 2014 | $391,000 | -32.0% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $575,000 | +5.9% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $543,000 | +17.5% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $462,000 | +69.9% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $272,000 | +21.4% | 100,000 | -1.4% | 0.00% | – |
| Q2 2013 | $224,000 | – | 101,468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Street Partners, LLC | 1,707,764 | $9,819,643,000 | 9.95% |
| SOPHROSYNE CAPITAL LLC | 951,362 | $5,472,000 | 5.57% |
| GREAT POINT PARTNERS LLC | 1,694,256 | $9,742,000 | 4.33% |
| INTREPID CAPITAL MANAGEMENT INC /DE/ | 436,148 | $2,508,000 | 2.19% |
| AVALON CAPITAL MANAGEMENT | 110,837 | $637,000 | 0.53% |
| Visium Asset Management, LP | 4,350,000 | $25,013,000 | 0.39% |
| Cheyne Capital Management (UK) LLP | 25,000 | $144,000 | 0.17% |
| Gruss Capital Management LP | 600,000 | $3,450,000 | 0.17% |
| Capital Impact Advisors, LLC | 31,206 | $179,000 | 0.14% |
| TFS CAPITAL LLC | 292,036 | $1,679,000 | 0.13% |